236 related articles for article (PubMed ID: 28684146)
1. Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.
Worley RR; Yang X; Fisher J
Toxicol Appl Pharmacol; 2017 Sep; 330():9-21. PubMed ID: 28684146
[TBL] [Abstract][Full Text] [Related]
2. Polyfluoroalkyl substance exposure in the Mid-Ohio River Valley, 1991-2012.
Herrick RL; Buckholz J; Biro FM; Calafat AM; Ye X; Xie C; Pinney SM
Environ Pollut; 2017 Sep; 228():50-60. PubMed ID: 28505513
[TBL] [Abstract][Full Text] [Related]
3. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community.
Savitz DA; Stein CR; Bartell SM; Elston B; Gong J; Shin HM; Wellenius GA
Epidemiology; 2012 May; 23(3):386-92. PubMed ID: 22370857
[TBL] [Abstract][Full Text] [Related]
4. Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant.
Barry V; Winquist A; Steenland K
Environ Health Perspect; 2013; 121(11-12):1313-8. PubMed ID: 24007715
[TBL] [Abstract][Full Text] [Related]
5. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts.
Winquist A; Steenland K
Epidemiology; 2014 Mar; 25(2):255-64. PubMed ID: 24407430
[TBL] [Abstract][Full Text] [Related]
6. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley.
Steenland K; Zhao L; Winquist A; Parks C
Environ Health Perspect; 2013 Aug; 121(8):900-5. PubMed ID: 23735465
[TBL] [Abstract][Full Text] [Related]
7. Variability and epistemic uncertainty in water ingestion rates and pharmacokinetic parameters, and impact on the association between perfluorooctanoate and preeclampsia in the C8 Health Project population.
Avanasi R; Shin HM; Vieira VM; Bartell SM
Environ Res; 2016 Apr; 146():299-307. PubMed ID: 26796985
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK model.
Loccisano AE; Campbell JL; Andersen ME; Clewell HJ
Regul Toxicol Pharmacol; 2011 Feb; 59(1):157-75. PubMed ID: 21168463
[TBL] [Abstract][Full Text] [Related]
9. A Permeability-Limited Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctanoic acid (PFOA) in Male Rats.
Cheng W; Ng CA
Environ Sci Technol; 2017 Sep; 51(17):9930-9939. PubMed ID: 28759222
[TBL] [Abstract][Full Text] [Related]
10. Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers.
Winquist A; Lally C; Shin HM; Steenland K
Environ Health Perspect; 2013 Aug; 121(8):893-9. PubMed ID: 23735518
[TBL] [Abstract][Full Text] [Related]
11. Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure.
Barry V; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2014 Jul; 132():62-9. PubMed ID: 24742729
[TBL] [Abstract][Full Text] [Related]
12. Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility.
Hoffman K; Webster TF; Bartell SM; Weisskopf MG; Fletcher T; Vieira VM
Environ Health Perspect; 2011 Jan; 119(1):92-7. PubMed ID: 20920951
[TBL] [Abstract][Full Text] [Related]
13. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community.
Seals R; Bartell SM; Steenland K
Environ Health Perspect; 2011 Jan; 119(1):119-24. PubMed ID: 20870569
[TBL] [Abstract][Full Text] [Related]
14. Perfluorooctanoic acid and chronic kidney disease: Longitudinal analysis of a Mid-Ohio Valley community.
Dhingra R; Lally C; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2016 Feb; 145():85-92. PubMed ID: 26656498
[TBL] [Abstract][Full Text] [Related]
15. Impact of Exposure Uncertainty on the Association between Perfluorooctanoate and Preeclampsia in the C8 Health Project Population.
Avanasi R; Shin HM; Vieira VM; Savitz DA; Bartell SM
Environ Health Perspect; 2016 Jan; 124(1):126-32. PubMed ID: 26090912
[TBL] [Abstract][Full Text] [Related]
16. Perfluorooctanoic acid exposure and natural menopause: A longitudinal study in a community cohort.
Dhingra R; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2016 Apr; 146():323-30. PubMed ID: 26802619
[TBL] [Abstract][Full Text] [Related]
17. Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water.
Li Y; Fletcher T; Mucs D; Scott K; Lindh CH; Tallving P; Jakobsson K
Occup Environ Med; 2018 Jan; 75(1):46-51. PubMed ID: 29133598
[TBL] [Abstract][Full Text] [Related]
18. Evaluating parameter availability for physiologically based pharmacokinetic (PBPK) modeling of perfluorooctanoic acid (PFOA) in zebrafish.
Khazaee M; Ng CA
Environ Sci Process Impacts; 2018 Jan; 20(1):105-119. PubMed ID: 29265128
[TBL] [Abstract][Full Text] [Related]
19. Toxicokinetics of perfluorooctanoate (PFOA) in rainbow trout (Oncorhynchus mykiss).
Consoer DM; Hoffman AD; Fitzsimmons PN; Kosian PA; Nichols JW
Aquat Toxicol; 2014 Nov; 156():65-73. PubMed ID: 25150511
[TBL] [Abstract][Full Text] [Related]
20. Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community.
Darrow LA; Groth AC; Winquist A; Shin HM; Bartell SM; Steenland K
Environ Health Perspect; 2016 Aug; 124(8):1227-33. PubMed ID: 26978841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
